tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

Moleculin Biotech’s Annamycin Highlighted at AACR 2025
Company AnnouncementsMoleculin Biotech’s Annamycin Highlighted at AACR 2025
1d ago
8K
MBRX
Moleculin Biotech Begins Phase 3 MIRACLE Trial Dosing
PremiumCompany Announcements
Moleculin Biotech Begins Phase 3 MIRACLE Trial Dosing
17d ago
8K
MBRX
Moleculin Biotech doses first patient in Phase 3 MIRACLE trial
PremiumThe Fly
Moleculin Biotech doses first patient in Phase 3 MIRACLE trial
17d ago
MBRX
Moleculin Biotech files to sell 18.2M shares of common stock for holders
PremiumThe Fly
Moleculin Biotech files to sell 18.2M shares of common stock for holders
18d ago
MBRX
Moleculin Biotech’s Promising Earnings Call Highlights
PremiumCompany Announcements
Moleculin Biotech’s Promising Earnings Call Highlights
24d ago
MBRX
Moleculin Biotech upgraded to Buy from Hold at Maxim
PremiumThe FlyMoleculin Biotech upgraded to Buy from Hold at Maxim
24d ago
MBRX
Moleculin Biotech Advances Clinical Trials Amid Financial Losses
Premium
Company Announcements
Moleculin Biotech Advances Clinical Trials Amid Financial Losses
25d ago
MBRX
Promising Advancements in Moleculin Biotech’s Annamycin Pivotal Trial Drive Buy Rating and $8 Price Target
Premium
Ratings
Promising Advancements in Moleculin Biotech’s Annamycin Pivotal Trial Drive Buy Rating and $8 Price Target
25d ago
MBRX
Moleculin Biotech Shares Corporate Presentation Update
PremiumCompany Announcements
Moleculin Biotech Shares Corporate Presentation Update
25d ago
8K
MBRX
Moleculin Biotech reports FY24 EPS ($6.32) vs. (15.07) last year
PremiumThe Fly
Moleculin Biotech reports FY24 EPS ($6.32) vs. (15.07) last year
25d ago
MBRX
MBRX Upcoming Earnings Report: What to Expect?
PremiumPre-Earnings
MBRX Upcoming Earnings Report: What to Expect?
1M ago
MBRX
Moleculin Biotech to be granted new patents for Annamycin
PremiumThe Fly
Moleculin Biotech to be granted new patents for Annamycin
1M ago
MBRX
Buy Rating for Moleculin Biotech: Accelerated Annamycin Development and Strategic Advancements
PremiumRatingsBuy Rating for Moleculin Biotech: Accelerated Annamycin Development and Strategic Advancements
2M ago
MBRX
Moleculin Biotech target adjusted to $8 from $45 at H.C. Wainwright
Premium
The Fly
Moleculin Biotech target adjusted to $8 from $45 at H.C. Wainwright
2M ago
MBRX
Biotech Alert: Searches spiking for these stocks today
Premium
The Fly
Biotech Alert: Searches spiking for these stocks today
2M ago
ACXP
ALLR
Moleculin Biotech announces pricing of $3.5M registered direct offering
PremiumThe Fly
Moleculin Biotech announces pricing of $3.5M registered direct offering
2M ago
MBRX
Moleculin Biotech Gets FDA Nod for Phase 3 Trial
PremiumCompany Announcements
Moleculin Biotech Gets FDA Nod for Phase 3 Trial
2M ago
8K
MBRX
Moleculin Biotech receives positive FDA guidance for acceleration of AML trial
PremiumThe Fly
Moleculin Biotech receives positive FDA guidance for acceleration of AML trial
2M ago
MBRX
Moleculin Biotech downgraded to Hold from Buy at Maxim
PremiumThe Fly
Moleculin Biotech downgraded to Hold from Buy at Maxim
2M ago
MBRX
Moleculin Biotech Gains European Approval for Phase 3 Trial
PremiumCompany AnnouncementsMoleculin Biotech Gains European Approval for Phase 3 Trial
2M ago
8K
MBRX
Moleculin Biotech receives first approval in Europe for AML trial recruiting
Premium
The Fly
Moleculin Biotech receives first approval in Europe for AML trial recruiting
2M ago
MBRX
Moleculin Biotech Launches MIRACLE Study for AML
Premium
Company Announcements
Moleculin Biotech Launches MIRACLE Study for AML
3M ago
8K
MBRX

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >